EGFR and non-small cell lung carcinoma: Almonertinib can inhibit the phosphorylation of mutant EGFR to block the downstream signal transduction by irreversibly binding to mutant EGFR, thereby inhibiting proliferation and inducing apoptosis of NSCLC cells.